Cresco Labs Inc. (CRLBF): Shareholders' Equity

Annual figures by period end, from SEC filings.

$340.45M
As of 2025-12-31
$505.69M2023-12-31: $505.69M2024-12-31: $474.85M2025-12-31: $340.45M$340.45M
2023-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$340.45M-28.3%2026-03-06, Balance as of period end
2024-12-31$474.85M-6.1%2026-03-06, Balance as of period end
2023-12-31$505.69Mn/a2025-03-14, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Cresco Labs Inc. (CRLBF)2025-12-31$340.45M-28.3%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31-$46.62Mn/m
Tilray Brands, Inc. (TLRY)2026-05-31$1.61B+6.8%
USANA Health Sciences Inc (USNA)2026-01-03$533.10M+0.2%
Trulieve Cannabis Corp. (TRLV)2025-12-31$1.14B-8.5%
Curaleaf Holdings, Inc. (CURLF)2025-12-31$756.35M-12.2%
Jushi Holdings Inc. (JUSH)2025-12-31-$115.34Mn/m
biote Corp. (BTMD)2025-12-31-$58.54Mn/m
Glass House Brands Inc. (GLAS)2025-12-31$73.94M-36.4%

Compare CRLBF, AAWH, TLRY, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗